Answers are grounded in this paper and cite their sources.
Cisplatin-mediated PD-L1 expression dependent on FOXP3 in bladder cancer cells. A, Expression of FOXP3 and PD-L1 in multiple bladder cancer cell lines without and with cisplatin stimulation by flow cytometry. The mean of at least three independent experiments, P values indicated. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. B, Expression of FOXP3 and PD-L1 in HT1376 CT and HT1376 FOXP3 KO cell lines without and with cisplatin stimulation by qPCR. The mean and SD of triplicates and representative of three independent experiments, P values indicated. C, Expression of FOXP3 and PD-L1 in HT1376 CT and HT1376 FOXP3 KO lines without and with IFNγ stimulation by Western blotting. Sizes are in kD as indicated. Full Western blots are shown in Supplementary Fig. S1. D, Flow cytometry of FOXP3 and PD-L1 expression of HT1376 CT and HT1376 FOXP3 KO lines without and with IFNγ stimulation. Representative of three independent experiments. E, Expression of FOXP3 and PD-L1 in HT1376 CT cells stimulated by IFNγ or cisplatin with control or depleting antibodies to IFNγ by flow cytometry. Representative of three independent experiments. Bar graphs represent the mean and SD of three independent experiments, P values indicated.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: